Yi Mufeng
Shanghai
About Yi Mufeng
Yi Mufeng develops innovative and breakthrough tumor immune technology products to benefit the majority of patients with solid tumors.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Total funding: $29.0M
- Funding stage: Early Stage Venture
- Last round: Series A (Dec 2022)
- Phone: +81 021-50907211
Industries & Categories
Biotechnology, Health Care, Medical
Canonical: https://fsome.com/organization/yi-mufeng-148786 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.